Category: Withdrawal

What withdrawal actually looks like, and why it is so often misread as the original condition returning.

Is Benzo Belly During a Benzodiazepine Taper Really IBS?

Why does the stomach trouble start in the middle of a benzodiazepine taper?

Because the gut is part of the withdrawal, and it is usually left out of the conversation. New bloating, cramping, diarrhea, or constipation are common enough during a taper that patient communities named the pattern benzo belly. The Ashton Manual lists gastrointestinal symptoms among the physical withdrawal symptoms in Chapter III, Table 1, and its section on digestive problems describes irritable bowel syndrome (IBS) appearing during or after withdrawal.

A stomach that was quiet for decades and turned on you two cuts into a taper is not a coincidence, and it is usually not a new disease. Unfortunately, the usual path runs the other way, to a specialist, a set of tests, and a functional diagnosis, which is the profession’s way of saying the tests were normal and the symptoms are real. So, what connects the gut to the taper, how do you tell withdrawal from something that needs checking, and what helps?

The gut has a nervous system of its own, and it uses the same brake.

Benzodiazepines work on a chemical messenger called gamma-aminobutyric acid, or GABA, the brain’s main calming signal. Boost that signal every day for months or years and the brain turns its own calming machinery down, until the dose is needed just to hold the line. That adjustment is physical dependence, the ordinary response of a body to a prescribed drug, and physical dependence is not addiction.

The brain is not the only place with a nervous system. The wall of the gut carries a dense network of nerve cells of its own, the enteric nervous system, enteric meaning of the intestines, which runs digestion largely by itself. GABA is a messenger in that network too, and Chapter III of the Ashton Manual notes that there are benzodiazepine receptors in the gut.

Here the evidence gets thinner. One theory is that the gut’s GABA signaling adapts to the medication alongside the brain’s and recalibrates with it when the dose comes down.

Yet, nobody has studied the gut in withdrawal the way the brain has been, so the theory rests on the receptors being there and on what patients describe. In clinical experience the pattern is consistent enough to treat as withdrawal, even though the mechanism is inferred rather than shown, and that experience varies from one prescriber to the next.

Professor Ashton’s own explanation leads with a different route. The autonomic nervous system, which sets the pace and the secretions of the gut, is overactive in withdrawal and very reactive to stress, and she allows that the gut’s own receptors may play some part as well. Both routes are probably at work at once.

One homely picture may help: an old house where a single dimmer switch runs the lights in two rooms, so that turning it down dims both, including the one nobody was thinking about. The analogy is imperfect, but the medication was never acting on the brain alone. So, when the gut flares after a cut, look first at the cut.

Benzo belly has a pattern, and it is worth learning.

Timing is the first clue. Symptoms that began during dose reductions, or in the weeks after the last dose, in a person with no history of gut trouble, are the typical presentation.

The second clue is that they keep time with the taper: a flare in the days after a cut, some easing during a hold, another flare after the next cut. Yet, primary IBS can swing between diarrhea and constipation too, and it does not check the calendar.

The third clue is the company the symptoms keep. Benzo belly usually travels with the rest of the nervous system stuck in overdrive: a heart that pounds at rest, sweats and chills, sound and light turned up too high, and sleep that will not come. An ordinary bowel complaint does not bring those along.

Sensation changes too, and many people describe a new awareness of digestion, every gurgle felt, and an ordinary amount of gas producing an outsized cramp. Foods that were fine for years start to bother, often with no consistent pattern, which points to a sensitized gut rather than a true new intolerance. A common pattern is a person who ate anything for fifty years and now keeps a list of what they can face for dinner.

Is it withdrawal, or is it something that needs checking?

Usually withdrawal, and a doctor should still make that call, because some things that look like IBS are not. The question the visit answers is whether anything about your case points away from the taper.

The features that matter are the ones any doctor asks about first: blood in the stool or black stools, weight you did not mean to lose, anemia or its pale, breathless feeling, pain or diarrhea that wakes you from sleep, fever, persistent vomiting, and a family history of bowel cancer or inflammatory bowel disease. Any of those earns an evaluation regardless of the taper, and so does a bowel screening that is overdue.

If a symptom could be an emergency, severe belly pain that does not let up, vomiting blood, chest pain, or a seizure, go to the emergency department, and let nothing about the taper slow you down. Short of that, a normal workup is good news: the withdrawal explanation stands, and anything else that turns up gets its own treatment.

One thing not to do is stop the benzodiazepine to see whether the gut settles. The 2020 label update from the Food and Drug Administration (FDA) warns that abrupt discontinuation or rapid dose reduction can bring on withdrawal reactions that include seizures and can be life-threatening, and the gut, being part of the withdrawal, gets worse with the rest of it.

What helps, and what is a conversation with your prescriber.

The taper pace comes first. Since the symptoms track the cuts, smaller reductions and longer holds ease the burden for many people in clinical experience, and that is a change you and your prescriber make together, in your own numbers, never from a schedule on a website. Dr. Leeds’ view is that a symptom this closely tied to dose changes is a message about the taper before it is a disease of the bowel.

Meals matter more than menus: simple, regular meals tend to sit better than long gaps followed by a large plate, and fluids matter on the days when diarrhea is the main complaint. While no diet treats withdrawal, some patients find that gentler eating helps, with smaller portions, fewer of the foods that clearly bother them, and a note of what happened, without turning the kitchen into a rulebook. A named diet is an individual question.

Medicines for the gut are a conversation, not a shopping list. Antispasmodics, medicines that slow diarrhea, and the sedating medicines often prescribed for IBS each have a place for some people and a cost for others, and some add drowsiness or dryness to a nervous system that is already sensitized. Your prescriber, who knows your taper, is the right person to weigh them, and the question to bring is whether a medicine is for this flare or for good.

How long does it last, and is it permanent?

The fear is that a gut that has turned on you will stay that way. Fortunately, in most cases it does not, but months of symptoms that come and go can feel permanent from the inside. Chapter III of the Ashton Manual, in Table 3 on protracted symptoms, lists gastrointestinal symptoms as gradually improving, though they may last a year and occasionally several.

Professor Ashton describes symptoms that wax and wane from day to day and week to week, with windows of normality that appear after some weeks, then grow more frequent and longer while the discomfort between them ebbs away. Patient communities call this windows and waves, and a bad week after a cut does not erase the good stretch before it.

For a smaller number of people, gut sensitivity lingers after the taper ends and overlaps with benzodiazepine-induced neurological dysfunction (BIND), the name for the longer-lasting injury some people carry. Even then, the Manual’s section on protracted gastrointestinal symptoms says they gradually abate with a normal balanced diet and sensible general health measures. At the other end of the range, Professor Ashton noted that some people have no digestive trouble in withdrawal at all, and may even enjoy their food more.

Treat it as withdrawal, and pace the taper.

Treated as one feature of withdrawal rather than an independent bowel disease, benzo belly is a reason to pause before committing to long-term IBS medication for a problem that is expected to leave, and to ask whether a medicine is for this flare or for good. Attention goes back to the taper pace and to calming the nervous system as a whole, and what calms the whole system, a paced day and protected sleep among them, calms the gut with it.

While your doctor may not have connected the stomach to the taper, it is fair to bring that connection to the visit yourself, with the dates of your cuts and your flares written down. A prescriber who can see the pattern on paper is often willing to slow the pace. From there, the gut heals on the same slow schedule as the rest of the nervous system, and the flare after every cut is often the first part of the pattern to fade.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.

May 6, 2026
Histamine Intolerance During Benzodiazepine Withdrawal: Is a Low-Histamine Diet Worth Trying?

Is a low-histamine diet worth trying during benzodiazepine withdrawal?

For some people, yes, as a short experiment with an end date written on the calendar before it starts. A low-histamine diet can tell you within a few weeks whether the food on your plate is adding to your symptoms. What it cannot do is heal the reason the reactions began.

If Tuesday’s leftover chili now does what Monday’s did not, you have probably met the phrase “histamine intolerance” in a forum, along with long food lists and a promise that eating around them will fix things. So, how much of that promise holds up?

Histamine intolerance is a framework, and not everyone accepts it.

Histamine is a chemical your own body makes and releases, and it is also in food, especially aged or fermented food. The framework says that some people take in more histamine than they can break down, and that the excess produces symptoms that look like an allergy without being one. The usual explanation is that a gut enzyme, diamine oxidase (DAO), is not keeping up.

That framework is contested, which is worth knowing before you reorganize your kitchen around it. The evidence for it is thin, and the food lists that come with it disagree about tomatoes, spinach, and whether a banana is a threat. Yet, the practical question survives: does eating this way change how you feel?

Professor C. Heather Ashton noticed the same reactions decades ago. In Chapter III of the Ashton Manual, under protracted gastrointestinal symptoms, she wrote that some people in withdrawal “develop apparent intolerance to certain foods” while tests for true food allergy “are nearly always negative.”

Why does histamine come up in withdrawal at all?

Nobody knows for certain, and the honest explanations we have are all hedged. One idea is that mast cells, the immune cells that store and release histamine, become easier to trigger while the nervous system is running hot. Another is that the autonomic nervous system, which the Ashton Manual says may be overactive in withdrawal, amplifies a small histamine release.

While the mechanism is uncertain, the timeline is not, and in Dr. Leeds’ view the timeline matters more: these reactions tend to ease as withdrawal does. Of course, none of this makes the reactions imaginary, and the allergy-like symptoms of benzodiazepine-induced neurological dysfunction (BIND) are part of the picture.

What does a histamine-type picture look like from the inside?

It looks like new reactions to particular foods within an hour or two of eating, rather than at random. Aged cheese, cured and smoked meat, sauerkraut and kimchi, kombucha, vinegar, canned or day-old fish, and alcohol are the usual offenders. Leftovers are a tell, because on this account histamine builds as food ages.

The symptoms tend to travel in a group: flushing, headache, a stuffy nose, a racing heart, itching or hives, stomach cramping, and a sudden low or anxious mood. A pattern patients often describe: months past the last dose, the small glass of wine that never used to bother them now brings on a hot face and a racing heart, and they have quietly stopped eating out. If the symptoms have no relationship to meals, the diet is unlikely to tell you much.

Some of these symptoms are not withdrawal and need to be checked.

Before any diet trial, a few patterns should send you to a doctor rather than to a food list. Hives with swelling of the lips, tongue, or throat, or with wheezing or trouble breathing, are not histamine intolerance and need emergency care the first time they happen. The same is true for flushing with chest pain or fainting: call 911, and do not let a forum talk you out of it.

Other red flags are quieter. Flushing with persistent diarrhea and weight loss, fever, blood in the stool, a reaction to one food every time no matter how fresh, or symptoms that began before the taper all deserve their own workup, because a true allergy, a gut infection, and a thyroid problem can each imitate this picture. Mast cell activation syndrome (MCAS) also comes up, and that is a diagnosis a physician makes with specific criteria, not a label from a checklist.

What does the diet actually involve?

While the exclusion list looks long, the principle is short: eat fresh and eat simply for a few weeks. Meat and fish are cooked and eaten the same day, fruit leans to apples, pears, and blueberries rather than citrus, most vegetables are fine, though most lists set aside tomatoes, spinach, eggplant, and avocado for the trial weeks, and grains, eggs, and fresh dairy suit many. Aged, fermented, cured, canned, and leftover foods come off the menu, and so does alcohol.

Sticking to it is harder than it sounds. Every meal has to be made fresh, eating out becomes a guessing game about how long the fish sat in the kitchen, and social meals get awkward fast.

The structured trial is the whole point.

A low-histamine diet run for two to four weeks, with a symptom diary and a planned reintroduction at the end, is a diagnostic experiment. The same diet run indefinitely because it seemed to help a little is an exclusion diet with no exit, and the Ashton Manual says plainly that it is “usually inadvisable to stick to a strict exclusion diet.”

The diary does the work. Each day, rate the two or three symptoms you care most about on a simple scale, note what you ate, and anything else that might explain a bad day, such as poor sleep or a taper step. In fact, memory is a poor instrument here, because a person who has just spent three weeks avoiding cheese wants the avoidance to have mattered.

At the end of the window, bring foods back one at a time, two or three days apart, with the diary still running. A clear reaction to one food is specific information about you. Or, if nothing much changed during the strict weeks, you have also learned something: histamine is not the main driver, the diet can end, and the search moves on.

Why not just stay on it, if it helps?

Because the reason it helps is expected to fade. The reactions belong to a nervous system unwinding from physical dependence on a drug taken as prescribed, and physical dependence is not addiction. Dependence is an adaptation, its slow reversal is what you are living through, and the food reactions are part of that reversal rather than a separate illness. The Ashton Manual’s table of protracted symptoms lists gastrointestinal symptoms as “gradually improving but may last a year and occasionally several years,” and Professor Ashton’s advice was a normal balanced diet while they abate.

There are costs on the other side too. A long, narrow diet raises nutritional questions worth reviewing with your doctor or a dietitian. And, in Dr. Leeds’ experience, long avoidance can breed its own problem: food becomes frightening, the safe list keeps shrinking, and reintroduction gets harder the longer it is put off.

What about antihistamines and the other medicines people mention?

That is an individual conversation with your prescriber. There are medicines that act on histamine receptors and medicines meant to steady mast cells, and some patients find one helpful while others feel nothing or feel worse. Which, if any, is reasonable for you depends on your other medicines and where you are in the taper, and some antihistamines add to the sedation of a benzodiazepine.

So, the medicine question is yours and your prescriber’s to settle. Enzyme capsules are sold on the theory that they replace what the gut is short of, and whether they do anything for a given person is unknown, so they too are a question for your doctor rather than a forum. Whatever you decide, a benzodiazepine is never stopped abruptly to see whether the reactions go away. The 2020 label update from the U.S. United States Food and Drug Administration (FDA) spells out why: stopping abruptly or reducing the dose too quickly “can result in withdrawal reactions, including seizures, which can be life-threatening.”

The reactions are real, and they are usually temporary.

A rain barrel is a fair picture of the framework, though not a perfect one. Histamine flows in from food and your own cells, a drain at the bottom carries it away, and symptoms appear when the water rises over a line near the rim. Withdrawal seems to narrow the drain and lower the line at once, so a normal day’s inflow overflows.

Where the picture fails is that the barrel is not fixed. As the nervous system settles, the drain widens again, so a diet that mattered in month three may not matter in month twelve. The one instruction the picture supports is to lower the inflow for a few weeks, watch the level, and see how much the barrel handles.

While it is tempting to build an identity around a diet that once helped, the better use of it is as a three-week question with a written answer. Run the trial, keep the diary, bring the foods back, and let the list of what you avoid get shorter as the months pass. Fortunately, for most people in withdrawal, it does.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.

April 29, 2026
Gabapentin Dependence: The Overlooked Deprescribing Challenge

Can you become dependent on gabapentin at the dose your doctor prescribed?

Yes, and it happens more quietly than with most medications a doctor hands out. Gabapentin, sold as Neurontin, and its close relative pregabalin, sold as Lyrica, belong to a small family called gabapentinoids, and both can leave you unable to stop without symptoms.

If you have tried to lower your dose and felt worse, you may already know this. What you may not have been told is that the feeling has a name, that it was predictable, and that it does not mean the original problem is back. How does a medication with a reputation for being harmless do that?

Dependence forms because the nervous system adapts to whatever it is given.

Gabapentin binds to part of the calcium channels that nerve cells use to release their signals, and the Neurontin label says plainly that the precise mechanism of its effects is unknown. What clinical experience shows is that a nervous system given a steady daily dose of any calming medication settles into a new normal that assumes the medication will be there.

One theory is that, when the medication is removed, the adaptation runs in reverse for a while, but the label describes no withdrawal mechanism. In clinical experience it happens at ordinary doses, in people who never took an extra capsule, whatever the label has or has not evaluated.

Physical dependence is not addiction. Dependence is a medical condition produced by a prescription taken exactly as written, and its treatment is a gradual, planned taper, not a program for a problem you do not have.

How do you notice gabapentin dependence?

Patients almost never describe it as dependence. They describe a missed or late dose that brought on anxiety, irritability, a headache, poor sleep, or the pain the medication was started for, within hours rather than days. When the next dose fixes it, most people conclude that they still need the medication.

A second tell is what happens when a reduction is attempted. Symptoms appear, they look like the original condition, and everyone concludes that it has come back. Pain or anxiety that returns within a day or two of a cut is more often the nervous system objecting than the old illness reappearing on cue.

The third tell shows up on a dose that has not changed in months: restlessness, poor sleep, a low hum of anxiety, or a fogginess that the next dose only partly relieves. A common pattern is a patient given gabapentin for nerve pain after an operation, kept on it for two years because nobody set a stop date, who meets all three tells in the week a refill runs late.

What does gabapentin withdrawal feel like?

It can feel a great deal like benzodiazepine withdrawal. Anxiety, insomnia, sweating, nausea, headache, a racing heart, tremor, and inner restlessness are the usual complaints, and the Neurontin label adds agitation, disorientation, and confusion after sudden stopping, in reports it describes as rare and mostly at higher than recommended doses. The label’s dependence section is thin and admits that dependence has not been evaluated in human studies.

The label is not thin about one thing. Gabapentin is an antiepileptic medication, and the label warns that these medications should not be stopped abruptly because seizures can increase, directing that any reduction or switch be made gradually over at least a week. Treat that week as a floor, not as a plan for a nervous system that has leaned on the medication for years.

A few things are never withdrawal until a doctor has said so. A seizure, chest pain, sudden loss of vision or hearing, new or worsening confusion, or thoughts of harming yourself are reasons to get emergency care now, not to wait and see, and if self-harm is in play, call or text 988 first. The label notes that antiepileptic medications can raise the risk of suicidal thoughts, so do not talk yourself out of that call because you assume it is the taper.

While you are still taking it, the label warns of drowsiness and dizziness, with a caution against driving until you know how it affects you, of serious slowed breathing when it is combined with other sedating medications, benzodiazepines among them, or in people whose breathing is already impaired, and, rarely, of a dangerous drug reaction with rash and fever.

Why do prescribers overlook it?

Gabapentin is usually added to a treatment plan rather than planned into it. It arrives to cover nerve pain during another taper, to help with sleep, or after an operation, and no one writes down the day it should end. The first prescription becomes the standing prescription without anyone deciding that it should.

The second reason is reputation. The Neurontin label states that gabapentin is not a scheduled drug. Some states control it on their own, and pregabalin is federally controlled, but in medicine we have tended to read “not scheduled” as though the nervous system had read the schedule too.

The third reason is diagnostic. When a reduction brings on anxiety, insomnia, or pain, the simplest explanation on the chart is that the original condition needs continued treatment. Withdrawal is rarely on the list, so the dose goes back up and the question is closed for another year.

Fortunately, gabapentin can be tapered, and the principles are familiar.

The Maudsley Deprescribing Guidelines give gabapentinoids their own chapter and apply the same approach they use for benzodiazepines. The taper begins from a stable place, a steady dose on a steady schedule until symptoms have settled, and only then comes the first small cut.

The cuts then shrink as the dose falls, in what the guidelines call a hyperbolic shape, because the last portion of the dose does a disproportionate share of the work. While a dimmer switch is not a perfect analogy, it holds in one respect: the first part of the turn barely changes the light and the last few degrees change it the most, so a steady hand slows down near the bottom. Cut smaller the lower you go.

Gabapentin comes in low-strength capsules and, according to the Neurontin label, in a commercial oral solution, so small cuts remain possible at the low end, and where a finer step is needed a compounding pharmacy can prepare a liquid. When symptoms flare after a cut, the dose is held until they settle, and if you take more than one dependence-forming medication, one comes down at a time.

What if the gabapentin was added during your benzodiazepine taper?

A prescriber adds it for the sleep, the pain, or the anxiety of a benzodiazepine taper, it helps for a while, and the patient who finishes the benzodiazepine finds a second medication waiting for its own taper. That is how much of the gabapentin dependence Dr. Leeds sees comes to light.

Dr. Leeds’ rule for anything added during a taper is that its exit plan is written on the day it is started. Anything added without one tends to stay, and the polypharmacy trap is built one helpful addition at a time. If you are offered gabapentin mid-taper, ask then how long it is meant to last and how it will come off.

If it was added years ago, the answer is not to hurry either medication. Finish the taper you are on, stabilize, and begin the second at the same careful pace, letting your prescriber judge which should come first.

Is the second taper really starting over?

No, although it can feel that way. A nervous system that has just finished a benzodiazepine taper is often still sensitized and quick to notice change, so a gabapentin taper taken too fast can hit as hard as the first one did. Some patients barely notice it, others need the same patience they needed the first time, and there is no knowing in advance.

Yet, you are not starting over. You already know what a window and a wave are, that holding is protection, and that a bad week after a cut is information rather than failure. And, when cuts stop working, the remedy is the one you learned the first time, a longer hold rather than a firmer resolve.

What should you ask your prescriber?

Begin with the question nobody asked at the start: what happens if I stop this? Follow it with what the deprescribing plan is, what a slow taper would look like, and whether a liquid form is available for small steps. A prescriber who has thought about gabapentin will have answers, and one who has not will at least have been asked.

An absent answer is itself useful, because it tells you the plan will have to be made now, with you in the room. The pace belongs to you as much as to the prescriber: if the taper is too fast, the doctor must slow it, and if it is comfortable, the two of you may agree to go a little faster, as tolerated.

That plan will look much like the one that already worked for you: a stable start, cuts that shrink as the dose falls, and holds when your body asks for them. You already know how to wait through a hard week, and now you know what to ask for.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.

April 16, 2026
Kindling and Benzodiazepines: Why Failed Tapers Make the Next One Harder

What does kindling mean when people talk about benzodiazepines?

Kindling is a borrowed word for a nervous system that has become more reactive after repeated abrupt stops. In medicine, we took the term from neurology, where it described a brain that seemed to learn to seize more easily each time it was provoked. In a benzodiazepine patient it describes a second or third withdrawal that arrives sooner, runs hotter, and lasts longer than the first, out of proportion to the dose.

The word carries its own picture, and it is the one analogy here. Kindling is the small dry wood that catches from a spark, and each time a fire is lit and stamped out, what is left behind catches faster than the fresh wood did. While a brain is not a woodpile, the picture explains why the sensible response is to stop striking sparks.

So, two questions remain. Is kindling real, and what should it change about the next attempt?

Why can a second taper feel harder than the first?

The brain compensates for a benzodiazepine by turning up its own excitability, and when the drug is removed faster than that compensation can unwind, the excess shows itself as withdrawal. Restarting the medication covers it up again, but there is no reason to think it undoes it.

A too-fast taper is usually not one event but three: a reduction that outran the nervous system, a stretch of severe withdrawal, and a reinstatement. In clinical experience, a nervous system that has lived through a full withdrawal episode tends to react more quickly and more strongly the next time the dose moves.

When the stops and restarts came from a prescriber rather than from you, the cycle has its own article. This piece is about a nervous system that already carries that history.

Is kindling proven, and what does the Ashton Manual say?

Kindling is not proven, and you deserve to hear that plainly. Nobody has settled what changes in the brain after repeated withdrawals, and the evidence for benzodiazepines is thinner than the confidence with which the word gets used. What we have is clinical experience, which varies from one physician to the next.

Dr. Leeds’ view is that the pattern is recognizable in the people who arrive after two or three failed attempts, and that a history of rapid withdrawals is a reason for more caution, never less. A gentle plan costs little if kindling turns out to be overstated.

The Ashton Manual does not use the word kindling at all. In fact, Chapter III, in its section on the course of withdrawal, says that eventual success in withdrawal is not affected by previous attempts at withdrawal. Professor C. Heather Ashton wrote that after years of running a withdrawal clinic.

Both statements can be true, because the manual’s reassurance is about where you end up and kindling is about how hard the next stretch is. The manual itself supplies the reason: Chapter II warns that abrupt or over-rapid withdrawal can produce severe symptoms including convulsions, and Chapter III observes that protracted symptoms are far less common in people who tapered slowly under their own control.

What harms a nervous system is the abruptness of a stop. So, a previous attempt counts against you only to the degree that it was abrupt, and the next one does not have to be abrupt at all.

Your symptoms on the last attempt were not in your head.

People who arrive after repeated failed tapers have often been told that their symptoms were anxiety or a personality trait. Some were told this by the same doctor who set the pace.

Physical dependence is not addiction. Dependence is the body’s adaptation to a medication taken exactly as prescribed, and withdrawal is what that adaptation looks like when the medication is removed faster than the body can adjust. A taper that did not hold was a pace problem, and pace, unlike a personality trait, can be changed.

Read as kindling, the same symptoms were the predictable response of a nervous system that had already been provoked once. That argues for a slower plan, and it gives you grounds to expect the plan to work.

Stabilize before you reduce anything.

The first move in a taper after failed attempts is to not taper. A nervous system that has just been through withdrawal and reinstatement needs weeks, and sometimes months, at one steady dose before it is ready for a reduction. None of that time is wasted, because nothing is being provoked.

Stable means predictable, not comfortable. While a rough stretch during a hold can feel like proof that the hold is failing, it is often the nervous system catching up with earlier changes, and the reasons a hold can feel worse have their own article.

A common pattern: someone came off in ten days at a facility, was restarted within a month, and tried again on a standard outpatient schedule. The second attempt stalled at the second cut, and what worked was three months at a steady dose before anyone touched it.

Cuts get smaller than last time, and they shrink as the dose falls.

If the pace that failed last time was the standard pace, the plan this time starts slower than that. The Ashton Manual’s schedules in Chapter II shrink each reduction as the dose comes down, and the Maudsley Deprescribing Guidelines describe reductions in proportion to the current dose. The right size is the one your nervous system tolerates, worked out with your prescriber one cut at a time.

Precision matters more in a reactive nervous system than in a calm one. Once the dose is below what tablets can be split evenly, a liquid formulation or a compounded preparation keeps each reduction exact, because a dose that varies from day to day is a series of small withdrawals. Unfortunately, precision is often the first thing a rushed plan gives up, and a kindled nervous system does not grade estimates generously.

A longer-acting benzodiazepine may smooth the ride.

Short-acting benzodiazepines wear off between doses, and the dip before the next dose is a small withdrawal in its own right. The Ashton Manual, in Chapter II, advises switching to a long-acting benzodiazepine such as diazepam because a short-acting drug cannot give a smooth decline in blood levels.

That switch is a crossover taper, done in stages over weeks rather than in one swap, and it is not right for everyone. Some people do not tolerate diazepam, so whether to make the change is a decision between you and a prescriber who knows the substitution well.

Hold through a flare, with a prescriber who will let you.

Flares happen even in a slow, precise taper. When one arrives, the first move is to stop reducing and stay where you are until the days become predictable again, and the Ashton Manual puts it plainly: if you reach a difficult point, you can stop there for a few weeks if necessary. The Manual adds that you should try to avoid going backwards, while the Maudsley Deprescribing Guidelines allow a return to the last dose at which you were stable, so the two references differ on that point. Whether a particular flare calls for a step back up to the previous dose is a decision for you and your prescriber to make together, case by case, and it is not one to answer alone.

The most reliable way to kindle a nervous system a third time is a prescriber who hears “I need to slow down” as resistance. So, part of preparing for the next attempt is finding someone who treats your account of the last one as clinical information. A discharge date is an administrative fact, and no nervous system has ever read one.

The Food and Drug Administration’s 2020 update to the benzodiazepine label warns that abrupt discontinuation or rapid dose reduction can bring on withdrawal reactions, including seizures, that can be life-threatening, and it calls for a gradual taper. Never stop a benzodiazepine suddenly on your own. If you have a seizure, chest pain, or a sudden loss of vision or hearing, or if you are thinking about harming yourself, call 911 or go to the nearest emergency department, and call or text 988 if self-harm is part of it.

What if you have already been through this two or three times?

Then you are the person the Ashton Manual’s reassurance was written for. Your previous attempts have not lowered your chances of finishing, and they have told you, at a high price, how fast your nervous system can be asked to move.

Fortunately, everything that made the earlier attempts fail can be changed on the next one. The pace, the size of each cut, the drug, the willingness to hold, and the person writing the plan are all decisions, and none of them is fixed by what happened before.

Yet, no physician can honestly give you a timeline, because the manual’s sentence says nothing about how long it takes. What you can hold on to is that the next attempt is made with a partner, at a pace the two of you set together, and that the last failed taper was the last time anyone needs to strike a spark.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.

April 16, 2026
Tolerance Withdrawal, or Why Benzo Symptoms Can Begin Before the Taper Does

Can you be in benzodiazepine withdrawal while taking every dose on time?

Yes, and it is easy for a prescriber to miss. A person who has taken a benzodiazepine for years, at the same dose, can slide into withdrawal without missing a pill. Chapter I of the Ashton Manual, in its section on tolerance, describes withdrawal symptoms emerging even in the continued presence of the drug, and patient communities call the state tolerance withdrawal.

Withdrawal is supposed to happen when a drug is taken away, and here the drug is still being taken. Yet, the symptoms are real, they are new, and they are usually answered with more of the medication that is producing them. So, what does tolerance withdrawal look like from the inside, why does an office visit miss it, and what changes once it has a name?

Tolerance is the brain adjusting to a drug that is always there.

Benzodiazepines work by strengthening the brain’s main calming signal, a chemical called gamma-aminobutyric acid, or GABA. When that signal is boosted every day for months or years, the brain adjusts by turning its own calming machinery down. In plain terms, the brakes weaken, and the dose that once produced calm now holds the line at best.

That adjustment is physical dependence, and physical dependence is not addiction. Nobody here has misused anything, and a brain that has adapted to a prescribed medication has a medical condition, treated with a gradual taper rather than a program.

The Ashton Manual puts the consequence plainly. The original dose has progressively less effect, anxiety often increases over the years despite continuous use, and panic attacks and agoraphobia may appear for the first time after years of taking the drug.

The first clue is that the symptoms are new.

Tolerance withdrawal is routinely mistaken for the original condition getting worse, so ask whether these symptoms were ever part of it. A person who started a benzodiazepine for panic attacks a decade ago and now has numbness around the mouth, tingling in the hands and feet, muscle twitching, an inner tremor, ringing in the ears, and a stomach that rejects ordinary food had none of that at the start. While anxiety is a plausible explanation for some of it, it is an implausible explanation for all of it at once.

Sensory and autonomic features are the ones most often reported as new: light too bright, sound too loud, a startle at ordinary noises, swings in temperature, and a heart that races without a reason. A common pattern in clinic is a person told, visit after visit, that their anxiety is progressing, when the anxiety they came in with was a fear of flying and what they have now is a fear of the supermarket lights.

The second clue is that the symptoms keep time with the clock.

On shorter-acting benzodiazepines such as alprazolam (Xanax) and lorazepam (Ativan), the blood level peaks and dips between doses, and Chapter II of the Ashton Manual, in its section on switching to a long-acting benzodiazepine, notes that many people experience a mini-withdrawal between each dose. In clinical experience, mornings can be the low point for the same reason, with agitation or a pounding heart that lifts an hour or two after the first dose.

The third clue is that a higher dose stops holding.

Dose increases stop holding: relief often lasts only a few weeks, and the symptoms return at the new dose. While this is not a perfect comparison, it is a little like a furnace running on one setting in a house that is slowly growing drafty: turning the dial up warms the rooms for a while, and then the drafts catch up. Look at the drafts, meaning the adaptation, rather than at the dial.

Some of these symptoms are not withdrawal until a doctor has checked.

Tolerance withdrawal is a pattern, and patterns can be imitated by a thyroid or rhythm problem, a vitamin deficiency, a nerve problem, or a medication started in the same window. Fortunately, most of what tolerance withdrawal produces is miserable rather than dangerous, and a few ordinary tests usually rule out the imitators.

Some symptoms should never be filed under withdrawal on your own. Chest pain or pressure, a racing heart with fainting, a first-ever seizure, a sudden loss of vision or hearing, weakness on one side of the body, new confusion, or a severe headache unlike any before need to be checked the same day, and if any of them is happening now, call 911 or go to the nearest emergency department. If you are having thoughts of harming yourself, call or text 988, the Suicide and Crisis Lifeline, now.

Why does a short visit miss it?

Unfortunately, the standard office visit is built to miss it. A patient on a long-term benzodiazepine says they feel more anxious, the visit has fifteen minutes in it, and the question that fits is whether the anxiety is worse, not whether it has changed shape. The pen is moving toward a higher dose before the tingling and the ringing ears have been mentioned.

There is an honest difficulty underneath the hurried one. Tolerance withdrawal and a genuine worsening of an anxiety disorder overlap, and we cannot measure a brain’s adaptation to a drug in an office. So, the distinction has to be made from the history, and the history is something only you can supply.

A higher dose or a second drug is the usual reflex, and the wrong one.

In medicine, we are trained to answer a worsening symptom by adding to the treatment, and the training serves well right up until the treatment is the cause. The brain adapts to a higher dose the way it adapted to the old one, and the ladder gains a rung. A second drug instead, most often a selective serotonin reuptake inhibitor, or SSRI, or a sedating medication for sleep, leaves the adaptation untouched and adds a medication that can carry its own dependence and withdrawal.

In fact, the reflex comes from the wish to relieve suffering, and in this one situation it points the wrong way. Dr. Leeds’ view is that recognizing tolerance changes the conversation from how much more to add to how to unwind what is already there, safely and slowly. Nothing in that conversation involves stopping suddenly, since the 2020 United States Food and Drug Administration (FDA) benzodiazepine label update warns that stopping abruptly, or reducing the dose too quickly, can bring on withdrawal reactions, including seizures, which can be life-threatening.

What does tolerance withdrawal change about the taper?

It changes the starting line. A person who is already in withdrawal experiences the first reductions on top of a baseline that already contains withdrawal, which is why the first stretch of a taper is often planned very slowly, sometimes after a hold.

Some patients report feeling steadier during the first weeks of a well-planned taper, which may reflect the end of dose increases and irregular timing. Clinicians who taper benzodiazepines see this often enough to mention it, but it is clinical experience, it varies, and no one should be told to expect it.

Timing can matter as much as amount. Spreading doses evenly across the day softens the dips that drive interdose symptoms, as the article on why a hold can feel worse than a cut explains.

For shorter-acting drugs, the Ashton Manual’s approach is a crossover taper to a longer-acting benzodiazepine, usually diazepam (Valium), chosen for its slow, smooth fall in blood level. The Maudsley Deprescribing Guidelines treat that switch as one tool among several rather than a universal step, and which path fits is a decision for you and your doctor.

What should you bring to the visit?

A dated timeline of symptoms is the most useful thing you can bring. Write down when each symptom first appeared, what the dose was at the time, and whether it comes and goes with the clock. Handwritten is fine, and a page of dates does more than an hour of description.

Bring a dose history as well: which drug, how much, how often, and every increase over the years with a rough date. Saying that these symptoms are new since the medication and follow the dosing schedule asks a different question than saying your anxiety is worse, and most doctors will engage with it.

Of course, a doctor may hesitate. You may raise it anyway, and ask whether a gradual taper, planned together, is worth discussing. The doctor must work out the pace with you, and one who has seen the timeline usually has an easier time saying yes.

Naming it early changes what the taper is doing from the first day.

In clinical experience, tolerance withdrawal is not rare, and it is often the first chapter of a story that ends, years later, in protracted withdrawal. That is an observation from practice, which varies, and not a rule.

A person who recognizes it early begins the taper knowing what the symptoms are, and that knowledge takes much of the fear out of the process. If dependence, tolerance, and toxicity are still tangled, the article on the difference between the three sorts them out.

The brain that adapted to the drug can adapt again in the other direction, on its own slow schedule, which no one can hurry. What you can do this week is start the timeline, and bring it to your next visit.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.

April 16, 2026